Protected: DO YOU TAKE YOUR CELLPHONE TO BED?

by | Apr 2, 2019 | Brain News Brief, Brain News Brief at NEINH, Brain News Brief at NEINH.com, brainnewsbrief.com, cellphone addiction, cellphone use, CGRP, Clinical Research, Clinical Trials, Dr. Kate Mullin, Dr. McAllister, Facebook, Gillian Neff, Gillian Neff Health Reports, headache, Instagram, LinkedIn, Lori Golias, NEINH, New England Institute for Neurology & Headache, Rebecca Surran, social media, spring reboot, Steven Baskin, The Migrainer, The Migrainer at NEINH, twitter, wellness

This content is password protected. To view it please enter your password below: Password: The post Protected: DO YOU TAKE YOUR CELLPHONE TO BED? appeared first on Brain News Brief.

“MY MIGRAINES VANISHED” – The Treatment That FINALLY Worked After 24 Years

by | Feb 10, 2019 | Aimovig, Amgen, Angelo Termine, brain, Brain News Brief, Brain News Brief at NEINH, Brain News Brief at NEINH.com, brainnewsbrief.com, CGRP, Dr. McAllister, Gillian Neff, Gillian Neff Health Reports, health, medical news, Medicine, migraine, monoclonal antibodies, NEICR, NEINH, New England Institute for Neurology & Headache, The Migrainer, The Migrainer at NEINH

“It was like an ice pick was right in my head, the pain was unbelievable,” says Margie Bliga Margie Bliga says she’s been hit with migraine headaches almost every day for 24 years. And she’s not the only one. Dr. Peter McAllister, of New...

ZERO COST CGRP MIGRAINE TREATMENT!?#

by | Oct 30, 2018 | Aimovig, Ajovy, Amgen, Brain News Brief, Brain News Brief at NEINH, brain research, CGRP, Clinical Research, Clinical Trials, Dr. Kate Mullin, Dr. Peter McAllister, Emgality, Gillian Neff, Gillian Neff Health Reports, headache, health, Lilly, medical news, Medicine, monoclonal antibodies, NEICR, NEINH, Teva, The Migrainer, The Migrainer at NEINH, The Migrainer.com

If you’re a frequent migraine sufferer and find yourself reaching for medication to stem the pain and nausea often, your doctor probably brought up the option of taking one of the new CGRP blockers. If the cost of it scared you off at first, listen to this:...

NEW CLASS OF DRUGS TO TURN OFF MIGRAINE AT ROOT – Clinical Trials of CGRP Drugs Accessible Now

by | Jul 31, 2017 | Angelo Termine, Brain News Brief at NEINH, CGRP, Clinical Trials, content, Dr. Peter McAllister, Gillian Neff, headache, NEINH, New England Institute for Clinical Research, New England Institute for Neurology & Headache, The Migrainer, The Migrainer at NEINH

Okay, I’ve done the math. I have experienced an estimated 2,880 days of migraine so far in life (12 per month X 20 years). If it wasn’t for the triptan medication I take, all of those days would have been 100% ruined. Many of them weren’t salvaged and the pain and...